US received most of the funding – EU promising, but at toddler stage Healthcare & Science ($2.3bn) 2008 72 35 32 27 11 10 10 9 9 3 2001 2006 2010 2010 2004 2013 2011 2013 2000 583 295 292 153 141 139 136 128 125 98 2013 2001 2012 2006 2011 2013 2007 Cloud-based services Health insurance Lead generation Analytics Disease monitoring Analytics Lead generation Analytics Analytics Lead generation 10% $0.2bn 9% $2.1bn EuropeUS 2008 2012 2012 Gesture capture Social network Disease monitoring Disease monitoring Lead generation Disease monitoring Analytics Lead generation Disease monitoring Lead generation 9 Source: Company disclosures, websites and press releases, Crunchbase, NOAH Advisors. Notes: Data only includes the 10 largest funding in the segment considered. 1. Acquired by MedImmune. Europe - Capital Raised ($m) / HQ / Year Founded US - Capital Raised ($m) / HQ / Year Founded Funding - Europe vs. US Most Active Investors in Europe Most Active Investors in the US Presenting at
NOAH Disruptor List Page 9 Page 11